19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cardiovascular risk and obesity

      review-article
      1 , 2 ,
      Diabetology & Metabolic Syndrome
      BioMed Central
      Obesity, Cardiovascular risk, Clinical assessment

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          This is an overview of the mechanisms of obesity and its relation to cardiovascular risks, describing the available treatment options to manage this condition.

          Main body

          The pathogenesis of obesity includes the balance between calories consumed and energy expenditure followed by the maintenance of body weight. Diet, physical activity, environmental, behavioral and physiological factors are part of the complex process of weight loss, since there are several hormones and peptides involved in regulation of appetite, eating behavior and energy expenditure. The cardiovascular complications associated to obesity are also driven by processes involving hormones and peptides and which include inflammation, insulin resistance, endothelial dysfunction, coronary calcification, activation of coagulation, renin angiotensin or the sympathetic nervous systems. Pharmacological treatments are often needed to insure weight loss and weight maintenance as adjuncts to diet and physical activity in people with obesity and overweight patients.

          Conclusion

          To accomplish satisfactory goals, patients and physicians seek for weight loss, weight maintenance and improvement of the risk factors associated to this condition, especially cardiovascular risk.

          Related collections

          Most cited references78

          • Record: found
          • Abstract: found
          • Article: not found

          Microbial ecology: human gut microbes associated with obesity.

          Two groups of beneficial bacteria are dominant in the human gut, the Bacteroidetes and the Firmicutes. Here we show that the relative proportion of Bacteroidetes is decreased in obese people by comparison with lean people, and that this proportion increases with weight loss on two types of low-calorie diet. Our findings indicate that obesity has a microbial component, which might have potential therapeutic implications.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

            The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A core gut microbiome in obese and lean twins

              The human distal gut harbors a vast ensemble of microbes (the microbiota) that provide us with important metabolic capabilities, including the ability to extract energy from otherwise indigestible dietary polysaccharides1–6. Studies of a small number of unrelated, healthy adults have revealed substantial diversity in their gut communities, as measured by sequencing 16S rRNA genes6–8, yet how this diversity relates to function and to the rest of the genes in the collective genomes of the microbiota (the gut microbiome) remains obscure. Studies of lean and obese mice suggest that the gut microbiota affects energy balance by influencing the efficiency of calorie harvest from the diet, and how this harvested energy is utilized and stored3–5. To address the question of how host genotype, environmental exposures, and host adiposity influence the gut microbiome, we have characterized the fecal microbial communities of adult female monozygotic and dizygotic twin pairs concordant for leanness or obesity, and their mothers. Analysis of 154 individuals yielded 9,920 near full-length and 1,937,461 partial bacterial 16S rRNA sequences, plus 2.14 gigabases from their microbiomes. The results reveal that the human gut microbiome is shared among family members, but that each person’s gut microbial community varies in the specific bacterial lineages present, with a comparable degree of co-variation between adult monozygotic and dizygotic twin pairs. However, there was a wide array of shared microbial genes among sampled individuals, comprising an extensive, identifiable ‘core microbiome’ at the gene, rather than at the organismal lineage level. Obesity is associated with phylum-level changes in the microbiota, reduced bacterial diversity, and altered representation of bacterial genes and metabolic pathways. These results demonstrate that a diversity of organismal assemblages can nonetheless yield a core microbiome at a functional level, and that deviations from this core are associated with different physiologic states (obese versus lean).
                Bookmark

                Author and article information

                Contributors
                +5511992639082 , fahfonseca@terra.com.br
                Journal
                Diabetol Metab Syndr
                Diabetol Metab Syndr
                Diabetology & Metabolic Syndrome
                BioMed Central (London )
                1758-5996
                28 August 2019
                28 August 2019
                2019
                : 11
                : 74
                Affiliations
                [1 ]ISNI 0000 0004 1937 0722, GRID grid.11899.38, Grupo de Obesidade e Síndrome Metabólica, Hospital das Clínicas, Faculdade de Medicina, , Universidade de São Paulo, ; São Paulo, Brazil
                [2 ]ISNI 0000 0001 0514 7202, GRID grid.411249.b, Escola Paulista de Medicina, , Universidade Federal de São Paulo, ; Rua Loefgren 1350, São Paulo, SP CEP 04040-001 Brazil
                Article
                468
                10.1186/s13098-019-0468-0
                6712750
                31467596
                1f0bca3b-7223-4f3e-b818-03a77f52ce3c
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 25 March 2019
                : 17 July 2019
                Funding
                Funded by: Novo Nordisk Farmacêutica do Brasil LTDA
                Categories
                Review
                Custom metadata
                © The Author(s) 2019

                Nutrition & Dietetics
                obesity,cardiovascular risk,clinical assessment
                Nutrition & Dietetics
                obesity, cardiovascular risk, clinical assessment

                Comments

                Comment on this article